{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis of clinical trials for hepatocellular carcinoma"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import numpy as np\n",
    "from bs4 import BeautifulSoup\n",
    "import lxml\n",
    "import pandas as pd\n",
    "import xml.etree.ElementTree as et\n",
    "from os import listdir\n",
    "from os.path import isfile, join"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## XML clinical trial data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Use Clinicaltrials.gov API to download trial information in XML format\n",
    "# https://clinicaltrials.gov/ct2/results/download_fields?cond=hepatocellular+carcinoma&down_count=1000&down_fmt=xml"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Use ElementTree\n",
    "tree = et.parse('data/ctgov_hcc_results/NCT00003147.xml')\n",
    "root = tree.getroot()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract facility information from XML. Add to dictionary of facilities with address information\n",
    "\n",
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "\n",
    "def get_facilities(trial_file):\n",
    "    \n",
    "    tree = et.parse(trial_file)\n",
    "    root = tree.getroot()\n",
    "\n",
    "    facility_dict = {}\n",
    "    \n",
    "    for i, facility in enumerate(root.findall('./location/facility')):\n",
    "        \n",
    "        address_tree = facility.find('address')\n",
    "        \n",
    "        # add elements to dictionary\n",
    "        address_dict = {}\n",
    "        \n",
    "        if address_tree.find('city') != None:\n",
    "            city = address_tree.find('city').text\n",
    "            address_dict['city'] = city\n",
    "        if address_tree.find('state') != None:\n",
    "            state = address_tree.find('state').text\n",
    "            address_dict['state'] = state\n",
    "        if address_tree.find('zip') != None:\n",
    "            zipcode = address_tree.find('zip').text\n",
    "            address_dict['zip'] = zipcode\n",
    "        if address_tree.find('country') != None:\n",
    "            country = address_tree.find('country').text\n",
    "            address_dict['country'] = country\n",
    "        \n",
    "        if facility.find('name') != None:\n",
    "            name = facility.find('name').text\n",
    "            facility_dict[name] = address_dict # add to facility dictionary\n",
    "        else:\n",
    "            facility_dict['unnamedFacility_' + str(i)] = address_dict # add to facility dictionary\n",
    "    \n",
    "    return facility_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract relevant trial information from XML file and input into dictionary\n",
    "\n",
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "\n",
    "def extract_trial_info(trial_file):\n",
    "    \n",
    "    with open(trial_file) as fp:\n",
    "        soup = BeautifulSoup(fp, \"xml\")\n",
    "    \n",
    "    trial_dict = {}\n",
    "    \n",
    "    trial_name = soup.nct_id.contents[0]\n",
    "    if soup.nct_id != None:\n",
    "        trial_dict['nct_id'] = soup.nct_id.contents[0]\n",
    "    if soup.brief_title != None:\n",
    "        trial_dict['brief_title'] = soup.brief_title.contents[0]\n",
    "    if soup.official_title != None:\n",
    "        trial_dict['official_title'] = soup.official_title.contents[0]\n",
    "    if soup.phase == True:\n",
    "        trial_dict['phase'] = soup.phase.contents[0]\n",
    "    if soup.overall_status != None:\n",
    "        trial_dict['status']= soup.overall_status.contents[0]\n",
    "    if soup.detailed_description != None:\n",
    "        trial_dict['description']= soup.detailed_description.textblock.contents[0]\n",
    "    if soup.eligibility:\n",
    "        if soup.eligibility.criteria != None:\n",
    "            trial_dict['criteria']= soup.eligibility.criteria.textblock.contents[0]\n",
    "        if soup.eligibility.gender:\n",
    "            trial_dict['gender']= soup.eligibility.gender.contents[0]\n",
    "        if soup.eligibility.minimum_age != None:\n",
    "            trial_dict['min_age']= soup.eligibility.minimum_age.contents[0]\n",
    "        if soup.eligibility.maximum_age != None:\n",
    "            trial_dict['max_age']= soup.eligibility.maximum_age.contents[0]\n",
    "    if soup.study_type != None:\n",
    "        trial_dict['study_type']= soup.study_type.contents[0]\n",
    "    if soup.brief_summary != None:\n",
    "        trial_dict['summary']= soup.brief_summary.textblock.contents[0]\n",
    "    trial_dict['facilities'] = get_facilities(trial_file)\n",
    "    \n",
    "    return trial_name, trial_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract clinical trial data from multiple XML files in folder\n",
    "\n",
    "def collect_trial_data(path, num_files=100):\n",
    "\n",
    "    files = listdir(path=path)\n",
    "    trials = {}\n",
    "    \n",
    "    i = 0\n",
    "    for file in files:\n",
    "        if i <= num_files:\n",
    "        \n",
    "            trial_file = path + file\n",
    "            trial_name, trial_dict = extract_trial_info(trial_file)\n",
    "            trials[trial_name] = trial_dict \n",
    "        i += 1\n",
    "    \n",
    "    return trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_folder = 'data/ctgov_hcc_results/'\n",
    "\n",
    "trials = collect_trial_data(path_folder, num_files=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>criteria</th>\n",
       "      <th>description</th>\n",
       "      <th>facilities</th>\n",
       "      <th>gender</th>\n",
       "      <th>max_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>status</th>\n",
       "      <th>study_type</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT00004108</th>\n",
       "      <td>DX-8951f in Treating Patients With Liver Cancer</td>\n",
       "      <td>DISEASE CHARACTERISTICS: Histological...</td>\n",
       "      <td>OBJECTIVES: I. Evaluate the antitumor a...</td>\n",
       "      <td>{'University of Colorado Cancer Center': {'cit...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>16 Years</td>\n",
       "      <td>NCT00004108</td>\n",
       "      <td>A Phase II Study of Intravenous DX-8951f Admin...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00005997</th>\n",
       "      <td>Rebeccamycin Analogue in Treating Patients Wit...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...</td>\n",
       "      <td>{'Comprehensive Cancer Center at University of...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00005997</td>\n",
       "      <td>Phase II and Pharmacokinetic Trial of Rebeccam...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00006332</th>\n",
       "      <td>Treatment of Hepatocellular Carcinoma With Tet...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'3912 Taubman Center': {'city': 'Ann Arbor', ...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00006332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a dea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00047346</th>\n",
       "      <td>Erlotinib in Treating Patients With Unresectab...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  His...</td>\n",
       "      <td>PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...</td>\n",
       "      <td>{'M D Anderson Cancer Center': {'city': 'Houst...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00047346</td>\n",
       "      <td>A Dose-Finding, Safety, And Pharmacokinetic St...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase I trial to study the effectivenes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00057395</th>\n",
       "      <td>A Safety and Effectiveness Study of Aroplatin ...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Adv...</td>\n",
       "      <td>Primary Objective:\n",
       "\n",
       "        -  Determin...</td>\n",
       "      <td>{'John Wayne Cancer Institute': {'city': 'Sant...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00057395</td>\n",
       "      <td>A Phase I/II Study of Aroplatin™ in Patients W...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>To determine the rate of response and t...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   brief_title  \\\n",
       "NCT00004108    DX-8951f in Treating Patients With Liver Cancer   \n",
       "NCT00005997  Rebeccamycin Analogue in Treating Patients Wit...   \n",
       "NCT00006332  Treatment of Hepatocellular Carcinoma With Tet...   \n",
       "NCT00047346  Erlotinib in Treating Patients With Unresectab...   \n",
       "NCT00057395  A Safety and Effectiveness Study of Aroplatin ...   \n",
       "\n",
       "                                                      criteria  \\\n",
       "NCT00004108  \n",
       "        DISEASE CHARACTERISTICS: Histological...   \n",
       "NCT00005997  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00006332  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT00047346  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  His...   \n",
       "NCT00057395  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Adv...   \n",
       "\n",
       "                                                   description  \\\n",
       "NCT00004108  \n",
       "      OBJECTIVES: I. Evaluate the antitumor a...   \n",
       "NCT00005997  \n",
       "      OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  \n",
       "      PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...   \n",
       "NCT00057395  \n",
       "      Primary Objective:\n",
       "\n",
       "        -  Determin...   \n",
       "\n",
       "                                                    facilities gender max_age  \\\n",
       "NCT00004108  {'University of Colorado Cancer Center': {'cit...    All     N/A   \n",
       "NCT00005997  {'Comprehensive Cancer Center at University of...    All     N/A   \n",
       "NCT00006332  {'3912 Taubman Center': {'city': 'Ann Arbor', ...    All     N/A   \n",
       "NCT00047346  {'M D Anderson Cancer Center': {'city': 'Houst...    All     N/A   \n",
       "NCT00057395  {'John Wayne Cancer Institute': {'city': 'Sant...    All     N/A   \n",
       "\n",
       "              min_age       nct_id  \\\n",
       "NCT00004108  16 Years  NCT00004108   \n",
       "NCT00005997  18 Years  NCT00005997   \n",
       "NCT00006332  18 Years  NCT00006332   \n",
       "NCT00047346  18 Years  NCT00047346   \n",
       "NCT00057395  18 Years  NCT00057395   \n",
       "\n",
       "                                                official_title  \\\n",
       "NCT00004108  A Phase II Study of Intravenous DX-8951f Admin...   \n",
       "NCT00005997  Phase II and Pharmacokinetic Trial of Rebeccam...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  A Dose-Finding, Safety, And Pharmacokinetic St...   \n",
       "NCT00057395  A Phase I/II Study of Aroplatin™ in Patients W...   \n",
       "\n",
       "                     status      study_type  \\\n",
       "NCT00004108       Completed  Interventional   \n",
       "NCT00005997      Terminated  Interventional   \n",
       "NCT00006332       Completed  Interventional   \n",
       "NCT00047346       Completed  Interventional   \n",
       "NCT00057395  Unknown status  Interventional   \n",
       "\n",
       "                                                       summary  \n",
       "NCT00004108  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00005997  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00006332  \n",
       "      Hepatocellular carcinoma (HCC) is a dea...  \n",
       "NCT00047346  \n",
       "      Phase I trial to study the effectivenes...  \n",
       "NCT00057395  \n",
       "      To determine the rate of response and t...  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials_df = pd.DataFrame(trials).transpose()\n",
    "trials_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# clean dataframe\n",
    "trials_df['min_age'] = trials_df['min_age'].str.replace('Years', '')\n",
    "trials_df['min_age'] = trials_df['min_age'].str.replace(' ', '')\n",
    "trials_df['min_age'].loc[trials_df['min_age'] == 'N/A'] = 0\n",
    "trials_df['min_age'] = trials_df['min_age'].apply(int)\n",
    "\n",
    "trials_df['max_age'] = trials_df['max_age'].str.replace('Years', '')\n",
    "trials_df['max_age'] = trials_df['max_age'].str.replace(' ', '')\n",
    "trials_df.loc[trials_df['max_age'] == 'N/A', 'max_age'] = 100\n",
    "trials_df.loc[trials_df['max_age'] == '10Days', 'max_age'] = 1\n",
    "trials_df['max_age'] = trials_df['max_age'].apply(int)\n",
    "\n",
    "trials_df['brief_title'] = trials_df['brief_title'].apply(str)\n",
    "trials_df['official_title'] = trials_df['official_title'].apply(str)\n",
    "trials_df['description'] = trials_df['description'].apply(str)\n",
    "trials_df['summary'] = trials_df['summary'].apply(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Create column with all the text from brief_title, official_title, and summary\n",
    "trials_df['text'] = trials_df['brief_title'] + ' ' + \\\n",
    "                    trials_df['official_title'] + ' ' + \\\n",
    "                    trials_df['description'] + ' ' + \\\n",
    "                    trials_df['summary']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Function to format and tokenize data\n",
    "def trial_tokenizer(description):\n",
    "    description = str(description)\n",
    "    description = description.replace('\\n', '').replace('\\t', '')\n",
    "    for i in range(3):\n",
    "        description = description.replace('  ', ' ')\n",
    "    description = description.lower()\n",
    "    \n",
    "    return description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "text = trials_df.text.apply(trial_tokenizer)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## NLP, matrix decomposition and clustering analysis of clinical trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from numpy.linalg import lstsq\n",
    "from numpy.linalg import norm\n",
    "import pandas as pd\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer\n",
    "from nltk import word_tokenize, sent_tokenize\n",
    "from sklearn.decomposition import NMF, TruncatedSVD"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### NLP of trial descriptions "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tf = TfidfVectorizer(max_features=5000, stop_words='english')\n",
    "\n",
    "doc_term_mat = tf.fit_transform(text.values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "terms = np.array(tf.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['000', '03', '04', ..., 'yttrium90', 'zd1839', 'μg'], \n",
       "      dtype='<U20')"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sklearn_nmf = NMF(max_iter=50, n_components=15)\n",
    "\n",
    "W = sklearn_nmf.fit_transform(doc_term_mat)\n",
    "H = sklearn_nmf.components_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Common Words:\n",
      "----------------------------------\n",
      "rfa\n",
      "hcc\n",
      "ablation\n",
      "radiofrequency\n",
      "recurrent\n",
      "hepatectomy\n",
      "patients\n",
      "recurrence\n",
      "cirrhosis\n",
      "pht\n",
      "ls\n",
      "treatment\n",
      "outcomes\n",
      "rate\n",
      "considered\n",
      "hr\n",
      "prognosis\n",
      "assisted\n",
      "small\n",
      "systemic\n",
      "\n",
      "\n",
      "Topic 1 Most Common Words:\n",
      "----------------------------------\n",
      "oxaliplatin\n",
      "plus\n",
      "leucovorin\n",
      "fluorouracil\n",
      "gemcitabine\n",
      "folfox4\n",
      "advanced\n",
      "liposomal\n",
      "doxorubicin\n",
      "chemotherapy\n",
      "versus\n",
      "oxa\n",
      "ld\n",
      "gemox\n",
      "hcc\n",
      "haic\n",
      "gem\n",
      "prolonging\n",
      "pfs\n",
      "superior\n",
      "\n",
      "\n",
      "Topic 2 Most Common Words:\n",
      "----------------------------------\n",
      "patients\n",
      "arsenic\n",
      "trioxide\n",
      "tumor\n",
      "treating\n",
      "dx\n",
      "ii\n",
      "days\n",
      "ihc\n",
      "progression\n",
      "dose\n",
      "rebeccamycin\n",
      "8951f\n",
      "growth\n",
      "toxicity\n",
      "disease\n",
      "receive\n",
      "months\n",
      "cancer\n",
      "liver\n",
      "\n",
      "\n",
      "Topic 3 Most Common Words:\n",
      "----------------------------------\n",
      "tace\n",
      "chemoembolization\n",
      "transarterial\n",
      "intermediate\n",
      "patients\n",
      "beads\n",
      "hcc\n",
      "deb\n",
      "cyberknife\n",
      "embolization\n",
      "eluting\n",
      "stage\n",
      "tate\n",
      "carcinoma\n",
      "hepatocellular\n",
      "efficacy\n",
      "treatment\n",
      "100\n",
      "doxorubicin\n",
      "sbrt\n",
      "\n",
      "\n",
      "Topic 4 Most Common Words:\n",
      "----------------------------------\n",
      "therasphere\n",
      "treatment\n",
      "glass\n",
      "microspheres\n",
      "90\n",
      "yttrium\n",
      "patients\n",
      "cancer\n",
      "cisplatin\n",
      "life\n",
      "device\n",
      "quality\n",
      "liver\n",
      "blood\n",
      "exemption\n",
      "humanitarian\n",
      "tumor\n",
      "surgery\n",
      "unresectable\n",
      "embolization\n",
      "\n",
      "\n",
      "Topic 5 Most Common Words:\n",
      "----------------------------------\n",
      "margin\n",
      "narrow\n",
      "cm\n",
      "radiation\n",
      "therapy\n",
      "radiotherapy\n",
      "vein\n",
      "hepatectomy\n",
      "pvtt\n",
      "portal\n",
      "rt\n",
      "current\n",
      "microvascular\n",
      "carcinomas\n",
      "types\n",
      "thrombosis\n",
      "treatment\n",
      "recurrence\n",
      "resection\n",
      "invasion\n",
      "\n",
      "\n",
      "Topic 6 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "solid\n",
      "dose\n",
      "safety\n",
      "enzalutamide\n",
      "cohort\n",
      "advanced\n",
      "efficacy\n",
      "study\n",
      "phase\n",
      "122\n",
      "cc\n",
      "label\n",
      "open\n",
      "evaluate\n",
      "31121\n",
      "opb\n",
      "197\n",
      "arq\n",
      "carcinoma\n",
      "\n",
      "\n",
      "Topic 7 Most Common Words:\n",
      "----------------------------------\n",
      "bsc\n",
      "plus\n",
      "placebo\n",
      "supportive\n",
      "best\n",
      "care\n",
      "pembrolizumab\n",
      "inc280\n",
      "advanced\n",
      "rad001\n",
      "study\n",
      "sorafenib\n",
      "treatment\n",
      "3475\n",
      "mk\n",
      "patients\n",
      "hepatocellular\n",
      "carcinoma\n",
      "240\n",
      "systemically\n",
      "\n",
      "\n",
      "Topic 8 Most Common Words:\n",
      "----------------------------------\n",
      "hcc\n",
      "patients\n",
      "hcv\n",
      "serum\n",
      "group\n",
      "included\n",
      "pivka\n",
      "afp\n",
      "abdominal\n",
      "golgi\n",
      "diagnosis\n",
      "using\n",
      "protein\n",
      "triphasic\n",
      "45\n",
      "control\n",
      "liver\n",
      "ct\n",
      "egyptian\n",
      "diagnostic\n",
      "\n",
      "\n",
      "Topic 9 Most Common Words:\n",
      "----------------------------------\n",
      "laparoscopic\n",
      "resection\n",
      "liver\n",
      "left\n",
      "parenchyma\n",
      "comparison\n",
      "division\n",
      "ultrasonic\n",
      "hydro\n",
      "dissection\n",
      "aspirator\n",
      "transection\n",
      "hepatectomy\n",
      "center\n",
      "prospective\n",
      "randomized\n",
      "minimally\n",
      "invasive\n",
      "advantages\n",
      "versus\n",
      "\n",
      "\n",
      "Topic 10 Most Common Words:\n",
      "----------------------------------\n",
      "transcatheter\n",
      "chemoembolization\n",
      "arterial\n",
      "adjuvant\n",
      "anti\n",
      "microsphere\n",
      "kmg\n",
      "radical\n",
      "therapy\n",
      "hepatocellular\n",
      "virus\n",
      "tace\n",
      "advance\n",
      "systemic\n",
      "carinomas\n",
      "dna\n",
      "cpg\n",
      "hepatitis\n",
      "carcinoma\n",
      "chemotherapy\n",
      "\n",
      "\n",
      "Topic 11 Most Common Words:\n",
      "----------------------------------\n",
      "sorafenib\n",
      "advanced\n",
      "combined\n",
      "haic\n",
      "biib022\n",
      "hcc\n",
      "rna\n",
      "tumor\n",
      "tosylate\n",
      "growth\n",
      "hcv\n",
      "pembrolizumab\n",
      "1b\n",
      "study\n",
      "hepatocellular\n",
      "vessels\n",
      "carcinoma\n",
      "celecoxib\n",
      "syndrome\n",
      "foot\n",
      "\n",
      "\n",
      "Topic 12 Most Common Words:\n",
      "----------------------------------\n",
      "vaccine\n",
      "tm\n",
      "hepatitis\n",
      "recombinant\n",
      "tumor\n",
      "anti\n",
      "phase\n",
      "process\n",
      "hcc\n",
      "crcl\n",
      "intradermal\n",
      "allostim\n",
      "injections\n",
      "cancer\n",
      "personalized\n",
      "new\n",
      "designed\n",
      "infection\n",
      "cells\n",
      "involves\n",
      "\n",
      "\n",
      "Topic 13 Most Common Words:\n",
      "----------------------------------\n",
      "contrast\n",
      "mri\n",
      "imaging\n",
      "liver\n",
      "enhanced\n",
      "radiation\n",
      "cht\n",
      "surveillance\n",
      "patients\n",
      "adc\n",
      "group\n",
      "ultrasonography\n",
      "non\n",
      "breathing\n",
      "lesions\n",
      "ct\n",
      "ultrasound\n",
      "therapy\n",
      "local\n",
      "investigators\n",
      "\n",
      "\n",
      "Topic 14 Most Common Words:\n",
      "----------------------------------\n",
      "transplant\n",
      "olt\n",
      "sirolimus\n",
      "orthotopic\n",
      "milan\n",
      "criteria\n",
      "transplantation\n",
      "pretransplant\n",
      "patients\n",
      "liver\n",
      "bleeding\n",
      "prior\n",
      "hcc\n",
      "post\n",
      "recurrence\n",
      "likelihood\n",
      "24\n",
      "grade\n",
      "hcv\n",
      "patient\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i, row in enumerate(H):\n",
    "    print(\"Topic\", i, \"Most Common Words:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = terms[np.argsort(row)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "Laparoscopic Surgery VS RFA for Recurrent HCC\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "\n",
      "\n",
      "Topic 1 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma\n",
      "Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Study of ARQ 197 in Hepatocellular Carcinoma (HCC)\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "Surefire Precision Infusion System Registry\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma\n",
      "Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 2 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery\n",
      "DX-8951f in Treating Patients With Liver Cancer\n",
      "Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer\n",
      "Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "\n",
      "\n",
      "Topic 3 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "TATE Versus TACE in Intermediate Stage HCC\n",
      "Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma\n",
      "Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma\n",
      "Surefire Precision Infusion System Registry\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "TACE Emulsion Versus Suspension\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "\n",
      "\n",
      "Topic 4 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery\n",
      "Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma\n",
      "Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors\n",
      "TACE Emulsion Versus Suspension\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "\n",
      "\n",
      "Topic 5 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis\n",
      "Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 6 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy\n",
      "Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma\n",
      "Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma\n",
      "A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)\n",
      "Study of ARQ 197 in Hepatocellular Carcinoma (HCC)\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "TACE Emulsion Versus Suspension\n",
      "Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "\n",
      "\n",
      "Topic 7 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.\n",
      "Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 8 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Golgi Protein for HCC Diagnosis\n",
      "Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir\n",
      "Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs\n",
      "Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 9 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection\n",
      "Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "Laparoscopic Surgery VS RFA for Recurrent HCC\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "\n",
      "\n",
      "Topic 10 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy\n",
      "Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas\n",
      "Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "TACE Emulsion Versus Suspension\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 11 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)\n",
      "Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 12 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "An Individualized Anti-Cancer Vaccine Study in Patients With HCC\n",
      "Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "\n",
      "\n",
      "Topic 13 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma\n",
      "Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]\n",
      "Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "\n",
      "\n",
      "Topic 14 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Surefire Precision Infusion System Registry\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "titles = trials_df['brief_title'].values\n",
    "\n",
    "for i in range(W.shape[1]):\n",
    "    topic_arr = W[:,i]\n",
    "    print(\"Topic\", i, \"Most Relevant Article Titles:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = titles[np.argsort(topic_arr)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sklearn_svd = TruncatedSVD(n_components=15)\n",
    "test_s = sklearn_svd.fit_transform(doc_term_mat)\n",
    "test_d = sklearn_svd.components_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Common Words:\n",
      "----------------------------------\n",
      "patients\n",
      "hcc\n",
      "sorafenib\n",
      "treatment\n",
      "study\n",
      "liver\n",
      "tumor\n",
      "hepatocellular\n",
      "carcinoma\n",
      "tace\n",
      "advanced\n",
      "chemoembolization\n",
      "cancer\n",
      "therapy\n",
      "rfa\n",
      "plus\n",
      "survival\n",
      "arterial\n",
      "safety\n",
      "phase\n",
      "\n",
      "\n",
      "Topic 1 Most Common Words:\n",
      "----------------------------------\n",
      "plus\n",
      "sorafenib\n",
      "oxaliplatin\n",
      "advanced\n",
      "bsc\n",
      "leucovorin\n",
      "fluorouracil\n",
      "gemcitabine\n",
      "folfox4\n",
      "supportive\n",
      "placebo\n",
      "best\n",
      "haic\n",
      "versus\n",
      "care\n",
      "liposomal\n",
      "hepatocellular\n",
      "carcinoma\n",
      "rad001\n",
      "pembrolizumab\n",
      "\n",
      "\n",
      "Topic 2 Most Common Words:\n",
      "----------------------------------\n",
      "hcc\n",
      "rfa\n",
      "tace\n",
      "hepatectomy\n",
      "resection\n",
      "recurrence\n",
      "recurrent\n",
      "ablation\n",
      "margin\n",
      "chemoembolization\n",
      "radiofrequency\n",
      "laparoscopic\n",
      "narrow\n",
      "prospective\n",
      "cm\n",
      "stage\n",
      "adjuvant\n",
      "intermediate\n",
      "transarterial\n",
      "versus\n",
      "\n",
      "\n",
      "Topic 3 Most Common Words:\n",
      "----------------------------------\n",
      "chemoembolization\n",
      "tace\n",
      "sorafenib\n",
      "arterial\n",
      "transcatheter\n",
      "transarterial\n",
      "combined\n",
      "intermediate\n",
      "hepatocellular\n",
      "anti\n",
      "hbv\n",
      "adjuvant\n",
      "kmg\n",
      "microsphere\n",
      "stage\n",
      "virus\n",
      "carcinoma\n",
      "combination\n",
      "therapy\n",
      "unresectable\n",
      "\n",
      "\n",
      "Topic 4 Most Common Words:\n",
      "----------------------------------\n",
      "sorafenib\n",
      "rfa\n",
      "hcv\n",
      "rna\n",
      "biib022\n",
      "olt\n",
      "transplant\n",
      "hcc\n",
      "ablation\n",
      "recurrence\n",
      "combined\n",
      "tosylate\n",
      "pembrolizumab\n",
      "group\n",
      "enhanced\n",
      "1b\n",
      "useful\n",
      "blood\n",
      "laparoscopic\n",
      "mri\n",
      "\n",
      "\n",
      "Topic 5 Most Common Words:\n",
      "----------------------------------\n",
      "margin\n",
      "narrow\n",
      "radiation\n",
      "cm\n",
      "radiotherapy\n",
      "vein\n",
      "therasphere\n",
      "portal\n",
      "therapy\n",
      "pvtt\n",
      "hepatectomy\n",
      "rt\n",
      "treatment\n",
      "tumor\n",
      "microvascular\n",
      "types\n",
      "current\n",
      "carcinomas\n",
      "thrombosis\n",
      "adjuvant\n",
      "\n",
      "\n",
      "Topic 6 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "dose\n",
      "solid\n",
      "phase\n",
      "safety\n",
      "cohort\n",
      "enzalutamide\n",
      "vaccine\n",
      "efficacy\n",
      "aroplatin\n",
      "malignancies\n",
      "evaluate\n",
      "122\n",
      "cc\n",
      "hepatitis\n",
      "open\n",
      "label\n",
      "hcc\n",
      "advanced\n",
      "margin\n",
      "\n",
      "\n",
      "Topic 7 Most Common Words:\n",
      "----------------------------------\n",
      "bsc\n",
      "placebo\n",
      "supportive\n",
      "best\n",
      "efficacy\n",
      "care\n",
      "pembrolizumab\n",
      "cyberknife\n",
      "radiation\n",
      "inc280\n",
      "imaging\n",
      "treatment\n",
      "rad001\n",
      "plus\n",
      "enzalutamide\n",
      "laparoscopic\n",
      "study\n",
      "vs\n",
      "safety\n",
      "subjects\n",
      "\n",
      "\n",
      "Topic 8 Most Common Words:\n",
      "----------------------------------\n",
      "hepatitis\n",
      "vaccine\n",
      "hcv\n",
      "plus\n",
      "virus\n",
      "ultrasonography\n",
      "radiation\n",
      "anti\n",
      "oxaliplatin\n",
      "serum\n",
      "eus\n",
      "recombinant\n",
      "group\n",
      "blood\n",
      "surveillance\n",
      "imaging\n",
      "therapy\n",
      "using\n",
      "transplant\n",
      "tm\n",
      "\n",
      "\n",
      "Topic 9 Most Common Words:\n",
      "----------------------------------\n",
      "laparoscopic\n",
      "resection\n",
      "liver\n",
      "surgery\n",
      "cisplatin\n",
      "therasphere\n",
      "left\n",
      "transcatheter\n",
      "blood\n",
      "randomized\n",
      "arterial\n",
      "parenchyma\n",
      "adjuvant\n",
      "controlled\n",
      "study\n",
      "life\n",
      "quality\n",
      "center\n",
      "88\n",
      "subjects\n",
      "\n",
      "\n",
      "Topic 10 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "cisplatin\n",
      "therasphere\n",
      "mitomycin\n",
      "sorafenib\n",
      "biib022\n",
      "oxaliplatin\n",
      "contrast\n",
      "fluorouracil\n",
      "mri\n",
      "enzalutamide\n",
      "radiation\n",
      "122\n",
      "cc\n",
      "label\n",
      "leucovorin\n",
      "open\n",
      "imaging\n",
      "drug\n",
      "blood\n",
      "\n",
      "\n",
      "Topic 11 Most Common Words:\n",
      "----------------------------------\n",
      "portal\n",
      "vein\n",
      "rt\n",
      "dose\n",
      "tumor\n",
      "apatinib\n",
      "pvtt\n",
      "radiation\n",
      "thrombus\n",
      "haic\n",
      "thrombi\n",
      "advanced\n",
      "hcc\n",
      "patients\n",
      "efficacy\n",
      "infusion\n",
      "safety\n",
      "registry\n",
      "comprehensive\n",
      "hepasphere\n",
      "\n",
      "\n",
      "Topic 12 Most Common Words:\n",
      "----------------------------------\n",
      "vaccine\n",
      "rfa\n",
      "recombinant\n",
      "subjects\n",
      "tm\n",
      "ablation\n",
      "pembrolizumab\n",
      "treatment\n",
      "hepatitis\n",
      "tumor\n",
      "anti\n",
      "process\n",
      "adenovirus\n",
      "tumors\n",
      "radiofrequency\n",
      "apatinib\n",
      "phase\n",
      "human\n",
      "bsc\n",
      "vein\n",
      "\n",
      "\n",
      "Topic 13 Most Common Words:\n",
      "----------------------------------\n",
      "life\n",
      "quality\n",
      "group\n",
      "adjuvant\n",
      "ablation\n",
      "transcatheter\n",
      "rfa\n",
      "patients\n",
      "octreotide\n",
      "local\n",
      "32p\n",
      "patient\n",
      "nutritional\n",
      "epa\n",
      "supplement\n",
      "dose\n",
      "surveys\n",
      "tumour\n",
      "sorafenib\n",
      "arterial\n",
      "\n",
      "\n",
      "Topic 14 Most Common Words:\n",
      "----------------------------------\n",
      "therasphere\n",
      "unresectable\n",
      "cyberknife\n",
      "dose\n",
      "protocol\n",
      "humanitarian\n",
      "exemption\n",
      "radiation\n",
      "device\n",
      "recombinant\n",
      "transarterial\n",
      "adenovirus\n",
      "transplant\n",
      "vaccine\n",
      "recurrent\n",
      "carcinoma\n",
      "treatment\n",
      "sorafenib\n",
      "injection\n",
      "type\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i, row in enumerate(test_d):\n",
    "    print(\"Topic\", i, \"Most Common Words:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = terms[np.argsort(row)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "### NLP of trial eligibility criteria"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['brief_title', 'criteria', 'description', 'facilities', 'gender',\n",
       "       'max_age', 'min_age', 'nct_id', 'official_title', 'status',\n",
       "       'study_type', 'summary', 'text'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials_df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "test = trials_df.criteria[4]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n        Inclusion Criteria:\\n\\n          -  Advanced solid malignancies;\\n\\n          -  Amenable to therapy with DACH platinum agents;\\n\\n          -  Measurable disease (RECIST criteria);\\n\\n          -  ECOG performance score of 0-2;\\n\\n          -  Adequate hematopoietic, liver and renal function;\\n\\n          -  Adequate cardiac function (maximum of class II, NYHA);\\n\\n          -  Women of childbearing potential must have a negative urine or serum pregnancy test;\\n\\n          -  Signed written informed consent;\\n\\n          -  Subjects must be willing to be followed during the course of treatment/observation and\\n             follow-up.\\n\\n        Exclusion Criteria:\\n\\n          -  No other active malignancies;\\n\\n          -  No prior therapy with oxaliplatin;\\n\\n          -  No known brain metastases;\\n\\n          -  Active, uncontrolled infection or other serious medical illnesses;\\n\\n          -  Not using or have used any investigational therapy during four weeks before start of\\n             protocol treatment.\\n      '"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n\\n          -  No other active malignancies;\\n\\n          -  No prior therapy with oxaliplatin;\\n\\n          -  No known brain metastases;\\n\\n          -  Active, uncontrolled infection or other serious medical illnesses;\\n\\n          -  Not using or have used any investigational therapy during four weeks before start of\\n             protocol treatment.\\n      '"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test.split('Exclusion Criteria:')[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "(?:world)(.*)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Create column with all the text from brief_title, official_title, and summary\n",
    "trials_df['text'] = trials_df['brief_title'] + ' ' + \\\n",
    "                    trials_df['official_title'] + ' ' + \\\n",
    "                    trials_df['description'] + ' ' + \\\n",
    "                    trials_df['summary']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
